Skip to main content
    O

    Opko Health Inc (OPK)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.62
    -0.06 (-3.57%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Opko Health Inc (OPK) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Opko Health (OPK) trades at 2.4x sales and 1.1x book value. Its P/S of 2.4x is above its 5-year median of 1.4x. Its forward P/E is 53.8x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E53.8x
    Price to sales2.4x
    Price to book1.1x
    PEGN/A
    FCF yield-11.2%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 60.0% above 1.5x and its P/B is 22.2% above 0.9x.

    MultipleCurrent5-year median10-year median
    P/S2.4x1.4x1.5x
    P/B1.1x0.8x0.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 0.9x in 2022 to 4.6x in 2016.

    Year endPriceP/EP/SP/B
    2025$1.26N/A1.8x0.8x
    2024$1.47N/A1.4x0.7x
    2023$1.51N/A1.3x0.8x
    2022$1.25N/A0.9x0.6x
    2021$4.81N/A1.8x1.9x
    2020$3.9579.0x1.8x1.5x
    2019$1.47N/A1.0x0.6x
    2018$3.01N/A1.7x1.0x
    2017$4.90N/A1.6x1.5x
    2016$9.30N/A4.6x2.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OPK

    What is OPK's forward P/E ratio?

    Opko Health has a forward P/E ratio of 53.8x.

    Is OPK stock overvalued?

    GNG's valuation label for OPK is Overvalued.

    What is OPK's price to sales ratio?

    Opko Health has a price to sales ratio of 2.4x.